14 Amendments of Miriam DALLI related to 2017/2951(RSP)
Amendment 2 #
Citation 15 a (new)
- having regard to Council Recommendation on seasonal influenza vaccination (2009);
Amendment 3 #
Recital B
B. whereas cost of a full vaccines package for one child, even at the lowest global prices, has increased by a factor of 68 from 2001 to 2014; whereas this price increase is unjustifiable and incompatible with the Sustainable Development Goal to ensure healthy lives and promote well- being at all ages;
Amendment 20 #
Paragraph 3
3. Points out that Vaccines are safe according to the WHO and the European Medicines Agency (EMA), as a licensed vaccine is rigorously tested across multiple phases of trials before its use is approved, and regularly reassessed once it is on the market;
Amendment 25 #
Paragraph 4
4. Welcomes the active engagement of the Commission on the issue of vaccination and the inclusion of a Joint Action Plan on vaccination, co-funded by the EU Health Programme, in the 2018 Commission Work Programmevaccination initiative in the 2018 Commission Work Programme; welcomes the publication of the roadmap for a Council Recommendation on strengthening cooperation against vaccine preventable diseases;
Amendment 30 #
Paragraph 4 a (new)
4 a. Welcomes the forthcoming launch of a Joint Action co-funded by the EU Health Programme aimed at increasing vaccination coverage;
Amendment 34 #
Paragraph 5
5. Strongly supports the Joint Procurement Agreement, which gives Member States and the Commission a framework to jointly procure vaccines, thereby pooling the purchasing power of Member States, ensuring that pandemic vaccines and other vaccines are available in sufficient quantities that access to vaccines is guaranteed, and that all participating Member States are treated equally;
Amendment 42 #
Paragraph 9
9. Calls on Member States to ensure that all healthcare workers are sufficiently vaccinated themselves; calls on the Commission to address the vaccination rates of healthcare workers in the Joint Action PlaCouncil Recommendation;
Amendment 58 #
Paragraph 12 a (new)
12 a. Emphasises the need for inclusive, factual and science-based information to citizens; calls on the Commission and Member States to facilitate dialogue with stakeholders from civil society, grass root movements, academia, media and national health authorities in order to combat unreliable, misleading and unscientific information on vaccination;
Amendment 62 #
Paragraph 13
13. Is concerned about the high prices and large differences in price of some life- saving vaccines within and outside the EU; calls on the Commission and the Member States to implement the measures called for in the European Parliament’s report of 14 February 2017 on EU options for improving access to medicines; further calls on the Commission to improve transparency in the cost of research, development and production of vaccines;
Amendment 64 #
Paragraph 13
13. Is concerned about the high prices of some life-saving vaccines and that this risks further exacerbating existing health inequalities in society; calls on the Commission and the Member States to implement the measures called for in the European Parliament’s report of 14 February 2017 on EU options for improving access to medicines;
Amendment 69 #
Paragraph 14 a (new)
14 a. Calls on the Commission to ensure that any development of new vaccines which receives public funding through the EU delivers more affordable end products by applying access conditions such as price ceilings or equitable licensing conditions;
Amendment 73 #
Paragraph 15 a (new)
15 a. Deplores the persisting inequalities between women and men in participation in clinical trials, which may hinder medicinal research and the development of vaccines for diseases where a majority of patients are women; calls on the Commission and Member States to take measures to eliminate this discriminating gender gap;
Amendment 77 #
Paragraph 16 a (new)
16 a. Is concerned by vaccine shortages and calls on the Commission and the Member States to develop solutions to increase vaccine supply and availability, including arrangements for stockpiling vaccines;
Amendment 90 #
Paragraph 19
19. Calls on the Commission to facilitate a more harmonised schedule for vaccination across the EU, to share best practice, to explore with Member States options to establish an EU platform for the monitoring of the safety and effectiveness of vaccines, to ensure even coverage across Europe and reduce health inequalities;